Developer docs
API playgroundTry for free, no card

Search company profiles

Sun Ophthalmics

Full company profile

uuid0009cn3

Namestring
Sun Ophthalmics
Legal namestring
Sun Pharmaceutical Industries Ltd.
Company typeenum
Public
Founded yearint
1983
Descriptiontext

The available source material for Sun Ophthalmics primarily describes Sun Pharma / Sun Pharmaceutical Industries Ltd.; ophthalmology appears as one of the therapeutic areas within Sun Pharma's Innovative Medicines business. The business serves patients and healthcare channels with pharmaceutical products across Innovative Medicines, Generic Products, and Consumer Healthcare, including specialty and retail products in dermatology, oncology, and ophthalmology.

The operating base is pharmaceutical R&D and manufacturing rather than a software platform. Sun Pharma is described as having an R&D pipeline for novel treatments, 2,000+ products, and more than 40 manufacturing facilities across five continents, with distribution through healthcare providers, hospitals, pharmacies, and global healthcare distribution networks.

Revenue is generated through pharmaceutical product sales across prescription, generic, and consumer healthcare channels; pricing details are not publicly disclosed in the supplied data. The source reports $6B+ in annual global revenue for Sun Pharma, with the U.S. market contributing approximately one-third, but it does not disclose standalone revenue or economics for a Sun Ophthalmics-only entity or ophthalmology segment.

Short descriptiontext

Sun Ophthalmics is represented in the data as Sun Pharma’s ophthalmology-related pharmaceutical activity, serving patients and healthcare channels through innovative medicines, generics and consumer healthcare products backed by global R&D, manufacturing and distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic pharmaceuticals, eye care treatments, specialty medicines, ophthalmology products, prescription therapeutics
Industry2 codes
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Ophthalmic Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Products
TypeOne Time License
Description

Sun Pharma generates revenue through a diversified portfolio spanning Innovative Medicines (specialty and retail), Generic Products, and Consumer Healthcare products. The company operates globally with the U.S. market contributing approximately one-third of global revenues.

sunpharma.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sun Ophthalmics is the ophthalmology-focused division of Sun Pharmaceutical Industries Ltd., developing and commercializing prescription ophthalmic pharmaceutical products as part of Sun Pharma's Innovative Medicines business unit. The ophthalmology therapeutic area operates alongside dermatology and oncology within Sun Pharma's broader specialty and retail pharmaceutical portfolio. Sun Ophthalmics leverages Sun Pharma's global pharmaceutical R&D and manufacturing infrastructure to deliver eye care treatments to patients, healthcare providers, and pharmacies primarily through U.S. market operations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sun Pharma operates as a global pharmaceutical company with a broadly diversified portfolio spanning three business units: Innovative Medicines (specialty and retail pharmaceuticals including dermatology, oncology, and ophthalmology), Generic Products, and Consumer Healthcare Products. The company offers 2,000+ products total, with manufacturing capabilities across more than 40 facilities on five continents. The ophthalmology focus appears under the Innovative Medicines business unit alongside dermatology and oncology therapeutic areas.

Product and service1 record
1Ophthalmology Therapeutic Area Products
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1External Innovation Partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sun Pharma actively seeks collaboration with external partners to bring breakthrough treatments to patients who need them, complementing internal R&D efforts. The company is interested in collaborating with external partners to bring breakthrough treatments to patients.

sunpharma.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sun Ophthalmics

Ophthalmic Pharmaceuticalssunophthalmics.com

Sun Ophthalmics is represented in the data as Sun Pharma’s ophthalmology-related pharmaceutical activity, serving patients and healthcare channels through innovative medicines, generics and consumer healthcare products backed by global R&D, manufacturing and distribution.

What Sun Ophthalmics does

The available source material for Sun Ophthalmics primarily describes Sun Pharma / Sun Pharmaceutical Industries Ltd.; ophthalmology appears as one of the therapeutic areas within Sun Pharma's Innovative Medicines business. The business serves patients and healthcare channels with pharmaceutical products across Innovative Medicines, Generic Products, and Consumer Healthcare, including specialty and retail products in dermatology, oncology, and ophthalmology.

The operating base is pharmaceutical R&D and manufacturing rather than a software platform. Sun Pharma is described as having an R&D pipeline for novel treatments, 2,000+ products, and more than 40 manufacturing facilities across five continents, with distribution through healthcare providers, hospitals, pharmacies, and global healthcare distribution networks.

Revenue is generated through pharmaceutical product sales across prescription, generic, and consumer healthcare channels; pricing details are not publicly disclosed in the supplied data. The source reports $6B+ in annual global revenue for Sun Pharma, with the U.S. market contributing approximately one-third, but it does not disclose standalone revenue or economics for a Sun Ophthalmics-only entity or ophthalmology segment.

Sun Ophthalmics firmographics

Firmographics
Name
Sun Ophthalmics
Legal name
Sun Pharmaceutical Industries Ltd.
Website
https://sunophthalmics.com
Company type
Public
Founded year
1983
Operating status
Operating
Headcount range
1–10 employees
Short description
Sun Ophthalmics is represented in the data as Sun Pharma’s ophthalmology-related pharmaceutical activity, serving patients and healthcare channels through innovative medicines, generics and consumer healthcare products backed by global R&D, manufacturing and distribution.
Ownership category
akta.pro rank

Sun Ophthalmics industry classification

Industry
Product category
Ophthalmic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Ophthalmic pharmaceuticals
  • Eye care treatments
  • Specialty medicines
  • Ophthalmology products
  • Prescription therapeutics

Where Sun Ophthalmics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Sun Ophthalmics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical Products: Sun Pharma generates revenue through a diversified portfolio spanning Innovative Medicines (specialty and retail), Generic Products, and Consumer Healthcare products. The company operates globally with the U.S. market contributing approximately one-third of global revenues.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Sun Ophthalmics product offering

Product offering

Core offering

Sun Ophthalmics is the ophthalmology-focused division of Sun Pharmaceutical Industries Ltd., developing and commercializing prescription ophthalmic pharmaceutical products as part of Sun Pharma's Innovative Medicines business unit. The ophthalmology therapeutic area operates alongside dermatology and oncology within Sun Pharma's broader specialty and retail pharmaceutical portfolio. Sun Ophthalmics leverages Sun Pharma's global pharmaceutical R&D and manufacturing infrastructure to deliver eye care treatments to patients, healthcare providers, and pharmacies primarily through U.S. market operations.

Product overview

Sun Pharma operates as a global pharmaceutical company with a broadly diversified portfolio spanning three business units: Innovative Medicines (specialty and retail pharmaceuticals including dermatology, oncology, and ophthalmology), Generic Products, and Consumer Healthcare Products. The company offers 2,000+ products total, with manufacturing capabilities across more than 40 facilities on five continents. The ophthalmology focus appears under the Innovative Medicines business unit alongside dermatology and oncology therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ophthalmology Therapeutic Area Products

Companies that use Sun Ophthalmics

Customer profile

Segments1 record

Ideal customer profiles1 record

Sun Ophthalmics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sun Ophthalmics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • External Innovation PartnersminorStrategic or Co-development PartnerSun Pharma actively seeks collaboration with external partners to bring breakthrough treatments to patients who need them, complementing internal R&D efforts. The company is interested in collaborating with external partners to bring breakthrough treatments to patients.

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Sun Ophthalmics competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Sun Ophthalmics social profiles

Digital presence

Sun Ophthalmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sun Ophthalmics leadership team

Management profile

Number of profiles

Sun Ophthalmics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sun Ophthalmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sun Ophthalmics

What does Sun Ophthalmics do?

Sun Ophthalmics is the ophthalmology-focused division of Sun Pharmaceutical Industries Ltd., developing and commercializing prescription ophthalmic pharmaceutical products as part of Sun Pharma's Innovative Medicines business unit. The ophthalmology therapeutic area operates alongside dermatology and oncology within Sun Pharma's broader specialty and retail pharmaceutical portfolio. Sun Ophthalmics leverages Sun Pharma's global pharmaceutical R&D and manufacturing infrastructure to deliver eye care treatments to patients, healthcare providers, and pharmacies primarily through U.S. market operations.

Is Sun Ophthalmics a public or private company?

Sun Ophthalmics is a public company. It is classified as corporate owned and is currently operating.

When was Sun Ophthalmics founded?

Sun Ophthalmics was founded in 1983. It employs 1 to 10 people.

Where is Sun Ophthalmics based?

Sun Ophthalmics is headquartered in New York, United States, in the North America region.

How does Sun Ophthalmics make money?

One revenue line is on record: pharmaceutical Products.

Does Sun Ophthalmics have an API?

No public API is recorded for Sun Ophthalmics.

What industry is Sun Ophthalmics in?

Sun Ophthalmics's product category is Ophthalmic Pharmaceuticals. Its primary akta.pro industry code is HLAIACAK, Ophthalmology Specialty Pharmaceuticals, with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales